Literature DB >> 2334559

Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device.

T R Graham1, K Dasse, A Coumbe, V Salih, M T Marrinan, O H Frazier, C T Lewis.   

Abstract

Implantable left ventricular assist systems are being developed for long term clinical use. Prototype devices are currently used as extended mechanical bridges to cardiac transplantation. The Thermo Cardiosystems Inc. (TCI) pneumatic pusher plate left ventricular assist device (LVAD) features textured blood contacting surfaces to encourage the formation of an adherent fibrin-cellular coagulum. This serves as the foundation for the development of a neo-intimal lining. The TCI LVAD was implanted in 6 male patients (age range 22-53 years) between 1986 and 1988. The duration of implantation ranged from 1-41 days. No clinical thromboembolic events or pump-related thromboembolism occurred and none was evident at necropsy. The six device linings have been fully evaluated. Explanted devices were free of thrombus and calcification. Lining samples for light and electron microscopy were collected from areas of the diaphragm identical for flex and blood shear conditions and from high and low shear areas on the static housing. Islands of collagenous tissue were deposited on the static housing amongst compact fibrin. By day 13, cells populated the surface of the developing neo-intima overlying the diaphragm. By 41 days, the surface cell density increased and the cells became spindle shaped and relatively orientated in the high shear/flex area. Immunohistochemical techniques suggest that these cells are of mesenchymal origin. Textured blood contacting surfaces appear satisfactory in the preliminary clinical use of this device.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334559     DOI: 10.1016/1010-7940(90)90002-h

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  Ventricular assist devices as a bridge to cardiac transplantation. A prelude to destination therapy.

Authors:  W L Holman; R C Bourge; R D Spruell; C P Murrah; D C McGiffin; J K Kirklin
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

2.  The need for artificial hearts.

Authors:  S Westaby
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

3.  Immunochemical identification of human endothelial cells on the lining of a ventricular assist device.

Authors:  O H Frazier; R T Baldwin; S G Eskin; J M Duncan
Journal:  Tex Heart Inst J       Date:  1993

Review 4.  Endocarditis in left ventricular assist device.

Authors:  Braghadheeswar Thyagarajan; Monisha Priyadarshini Kumar; Rutuja R Sikachi; Abhinav Agrawal
Journal:  Intractable Rare Dis Res       Date:  2016-08

5.  Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.

Authors:  Mark S Slaughter; Michael A Sobieski; Colleen Gallagher; Muhyaldeen Dia; Marc A Silver
Journal:  Tex Heart Inst J       Date:  2008

6.  A novel platelet concentrate: titanium-prepared platelet-rich fibrin.

Authors:  Mustafa Tunalı; Hakan Özdemir; Zafer Küçükodacı; Serhan Akman; Emre Yaprak; Hülya Toker; Erhan Fıratlı
Journal:  Biomed Res Int       Date:  2014-01-21       Impact factor: 3.411

Review 7.  Strategies and First Advances in the Development of Prevascularized Bone Implants.

Authors:  Christoph Rücker; Holger Kirch; Oliver Pullig; Heike Walles
Journal:  Curr Mol Biol Rep       Date:  2016-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.